Pancreatic Cancer Research

ResearcherShandong UniversityNo recent work listed

Kai Cui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8406-6549; OpenAlex author ID A5046031394. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2011: 3 papers · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 4

  1. Gene Expression Profiles in Chemokine (C-C Motif) Ligand 21-Overexpressing Pancreatic Cancer Cells. Co-author DOI 10.1007/s12253-018-0390-z↗
  2. The chemotactic interaction between CCL21 and its receptor, CCR7, facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangio… First author DOI 10.1007/s00534-011-0395-4↗
  3. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis. Co-author DOI 10.1016/j.jss.2010.03.001↗
  4. Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis. Co-author PMID 22320973↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sheng Li · 3 shared papers, 2011–2020 · strength 0.17
  2. Bo Zhang · 2 shared papers, 2011 · strength 0.05
  3. Wuyuan Zhou · 2 shared papers, 2011 · strength 0.05
  4. Bin Zhao · 1 shared paper, 2011 · strength 0.03
  5. Jinming Yu · 1 shared paper, 2011 · strength 0.03
  6. Sheng Li · 1 shared paper, 2011 · strength 0.02
  7. Bin Zhao · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.